Dow Up0.12% Nasdaq Up1.35%

Covance Inc. (CVD)

-NYQ
77.73 0.24(0.31%) Oct 20, 4:01PM EDT
CompetitorsGet Competitors for:
Direct Competitor Comparison 
CVDCRLPVT1QIndustry
Market Cap:4.39B2.82BN/A6.97B215.84M
Employees:11,8637,700N/A30,700433.00
Qtrly Rev Growth (yoy):0.080.17N/A0.100.16
Revenue (ttm): 2.49B1.22BN/A3.98B74.06M
Gross Margin (ttm):0.300.35N/A0.360.47
EBITDA (ttm):402.42M272.37MN/A635.83M-677.36K
Operating Margin (ttm): 0.110.14N/A0.14-0.03
Net Income (ttm):157.80M118.57MN/A315.07MN/A
EPS (ttm):2.742.44N/A2.37N/A
P/E (ttm):28.3924.72N/A23.1524.37
PEG (5 yr expected):1.401.82N/A1.521.38
P/S (ttm):1.762.34N/A1.773.32
 
CRL = Charles River Laboratories International, Inc.
Pvt1 = Pharmaceutical Product Development, LLC (privately held)
Q = Quintiles Transnational Holdings Inc.
Industry = Medical Laboratories & Research

 
News on Direct Competitors 

Currency in USD.